AU2003237598A8 - Process for the preparation of highly pure rabeprazole sodium salt - Google Patents
Process for the preparation of highly pure rabeprazole sodium saltInfo
- Publication number
- AU2003237598A8 AU2003237598A8 AU2003237598A AU2003237598A AU2003237598A8 AU 2003237598 A8 AU2003237598 A8 AU 2003237598A8 AU 2003237598 A AU2003237598 A AU 2003237598A AU 2003237598 A AU2003237598 A AU 2003237598A AU 2003237598 A8 AU2003237598 A8 AU 2003237598A8
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- sodium salt
- highly pure
- rabeprazole sodium
- pure rabeprazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN419/MAS/2002 | 2002-06-03 | ||
| IN419CH2002 | 2002-06-03 | ||
| PCT/IN2003/000208 WO2003101452A1 (en) | 2002-06-03 | 2003-06-02 | Process for the preparation of highly pure rabeprazole sodium salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003237598A8 true AU2003237598A8 (en) | 2003-12-19 |
| AU2003237598A1 AU2003237598A1 (en) | 2003-12-19 |
Family
ID=29596801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003237598A Abandoned AU2003237598A1 (en) | 2002-06-03 | 2003-06-02 | Process for the preparation of highly pure rabeprazole sodium salt |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003237598A1 (en) |
| WO (1) | WO2003101452A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1660083A4 (en) * | 2003-08-18 | 2009-03-25 | Cadila Pharmaceuticals Ltd | Stable pharmaceutical composition of rabeprazole |
| WO2006003946A1 (en) | 2004-06-30 | 2006-01-12 | Eisai R & D Management Co., Ltd. | Process for production of benzimidazole derivative salt precipitates |
| ITMI20042437A1 (en) * | 2004-12-21 | 2005-03-21 | Dipharma Spa | CRYSTALLINE FORM OF RABEPRAZOLO SODICO |
| ITMI20062449A1 (en) | 2006-12-19 | 2008-06-20 | Dipharma Spa | CRYSTALLINE FORM OF RABEPRAZOLO SODICO |
| US8247568B2 (en) | 2007-06-21 | 2012-08-21 | Matrix Laboratories Ltd | Process for the preparation of pure rabeprazole |
| WO2011004281A1 (en) | 2009-07-09 | 2011-01-13 | Alembic Limited | A process for the preparation of amorphous form of rabeprazole sodium |
| CN102949354B (en) * | 2012-11-01 | 2014-02-26 | 江苏奥赛康药业股份有限公司 | Sodium rabeprazole composition for injection |
| WO2014091450A1 (en) | 2012-12-12 | 2014-06-19 | Ranbaxy Laboratories Limited | Process for the preparation of rabeprazole |
| CN104119315B (en) * | 2014-05-21 | 2016-03-02 | 丽珠医药集团股份有限公司 | A kind of preparation method of Sodium rabeprazole |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2166269B1 (en) * | 1999-07-14 | 2003-04-01 | Sint Quimica Sa | NEW PROCEDURE FOR OBTAINING DERIVATIVES OF 2- (2-PIRIDINILMETILSULFINIL) -1H-BENZIMIDAZOL. |
| US7396841B2 (en) * | 2000-08-18 | 2008-07-08 | Takeda Pharmaceutical Company Limited | Injections |
-
2003
- 2003-06-02 AU AU2003237598A patent/AU2003237598A1/en not_active Abandoned
- 2003-06-02 WO PCT/IN2003/000208 patent/WO2003101452A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003101452A8 (en) | 2004-03-11 |
| WO2003101452A1 (en) | 2003-12-11 |
| AU2003237598A1 (en) | 2003-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL189657A (en) | Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives | |
| GB2395946B (en) | Method for the production of sodium chloride from seawater | |
| IL216449A0 (en) | Process for the preparation of tetrazole derivatives | |
| IL173456A0 (en) | Process for the preparation of 4-amino-3-quinolinecarbonitriles | |
| IL169128A0 (en) | Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation | |
| ZA200507297B (en) | Process for preparation of phenethylamine derivatives | |
| IL175743A0 (en) | Process for the preparation of thiazolopyrimidines | |
| GB2436262B (en) | Process for the preparation of pantoprazole sodium | |
| IL175156A0 (en) | Process for the preparation of gabapentin | |
| AU2003237598A8 (en) | Process for the preparation of highly pure rabeprazole sodium salt | |
| AU2003224781A1 (en) | Crystalline forms of rabeprazole sodium | |
| IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
| EP1646640A4 (en) | Method for the preparation of highly pure 1-androstene derivatives | |
| HUP0400080A3 (en) | Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate | |
| EP1554298A4 (en) | Process for the preparation of 9-beta-anomeric nucleoside analogs | |
| MY136695A (en) | Process for the preparation of alkylaryl compounds | |
| AU2003278420A8 (en) | Process for the preparation of ganciclovir | |
| HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
| PL371583A1 (en) | Process for the preparation of 7alpha-methylsteroids | |
| SG111997A1 (en) | Improved process for the preparation of polyalkylphenoxyaminoalkanes | |
| AU2003256006A8 (en) | Improved process for preparation of risperidone | |
| IL149771A0 (en) | Process for preparation of torsemide | |
| EP1516868A4 (en) | Process for the preparation of dimethylamine | |
| IL164788A0 (en) | Process for the preparation of 3-isochromanone | |
| HK1087111A1 (en) | Process for the preparation of nicotinaldehydes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |